CHEMBIO DIAGNOSTICS INC (CEMI) Stock Price, Quote, News and Overview
NASDAQ:CEMI - Nasdaq - US1635722093 - Common Stock - Currency: USD
CEMI Quote, Performance and Key Statistics
0.455
+0 (+0.22%)
The current stock price of CEMI is 0.455 USD. In the past month the price increased by 5.79%. In the past year, price decreased by -20.97%.
CEMI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 30.34 | 46.24B | ||
| COO | COOPER COS INC/THE | 21.09 | 15.90B | ||
| ALGN | ALIGN TECHNOLOGY INC | 18.35 | 12.55B | ||
| SOLV | SOLVENTUM CORP | 9.9 | 11.46B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.94 | 6.94B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 26.12 | 5.37B | ||
| BLCO | BAUSCH + LOMB CORP | 19.45 | 4.26B | ||
| ICUI | ICU MEDICAL INC | 22.29 | 3.41B | ||
| HAE | HAEMONETICS CORP/MASS | 13.52 | 2.87B | ||
| XRAY | DENTSPLY SIRONA INC | 7.68 | 2.56B | ||
| UFPT | UFP TECHNOLOGIES INC | 27.77 | 1.62B | ||
| NEOG | NEOGEN CORP | 11.55 | 952.81M |
Related stock screener links
About CEMI
Company Profile
Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. The company is headquartered in Medford, New York and currently employs 188 full-time employees. The company went IPO on 2000-10-18. Its product portfolio is based upon its DPP technology, a diagnostic platform that provides results in 15 to 20 minutes using fingertip blood, nasal swabs, and other sample types. The DPP technology platform addresses the rapid diagnostic test market, which includes infectious diseases such as sexually transmitted infections (STIs) and human immunodeficiency virus (HIV), gastroenterology, and women's health. Its products include COVID-19 Antibody Test System, COVID-19 Antigen Test System, COVID-19 and Influenza Respiratory Antigen Panel Test System and HIV-Syphilis Diagnostic Test Systems, among others. The company is also targeting lateral flow test solutions for infectious diseases.
Company Info
CHEMBIO DIAGNOSTICS INC
555 Wireless Blvd, 3661 Horseblock Road
Medford NEW YORK 11788 US
CEO: Richard L. Eberly
Employees: 188
Company Website: http://chembio.com/
Phone: 16319241135.0
CHEMBIO DIAGNOSTICS INC / CEMI FAQ
What is the stock price of CHEMBIO DIAGNOSTICS INC today?
The current stock price of CEMI is 0.455 USD. The price increased by 0.22% in the last trading session.
What is the ticker symbol for CHEMBIO DIAGNOSTICS INC stock?
The exchange symbol of CHEMBIO DIAGNOSTICS INC is CEMI and it is listed on the Nasdaq exchange.
On which exchange is CEMI stock listed?
CEMI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CHEMBIO DIAGNOSTICS INC stock?
6 analysts have analysed CEMI and the average price target is 8.16 USD. This implies a price increase of 1693.41% is expected in the next year compared to the current price of 0.455. Check the CHEMBIO DIAGNOSTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CHEMBIO DIAGNOSTICS INC worth?
CHEMBIO DIAGNOSTICS INC (CEMI) has a market capitalization of 16.71M USD. This makes CEMI a Nano Cap stock.
How many employees does CHEMBIO DIAGNOSTICS INC have?
CHEMBIO DIAGNOSTICS INC (CEMI) currently has 188 employees.
What are the support and resistance levels for CHEMBIO DIAGNOSTICS INC (CEMI) stock?
CHEMBIO DIAGNOSTICS INC (CEMI) has a support level at 0.45 and a resistance level at 0.47. Check the full technical report for a detailed analysis of CEMI support and resistance levels.
Should I buy CHEMBIO DIAGNOSTICS INC (CEMI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CEMI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CEMI, evaluating the profitability, health, valuation and growth aspects
- CHEMBIO DIAGNOSTICS INC (CEMI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CHEMBIO DIAGNOSTICS INC (CEMI) Sales and EPS estimates to see what analysts future expectations are.
- CHEMBIO DIAGNOSTICS INC (CEMI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CHEMBIO DIAGNOSTICS INC (CEMI) Insider and Institutional Ownership to learn about the owners and their transactions.
- CHEMBIO DIAGNOSTICS INC (CEMI) Stock Chart to make your own analysis
- CHEMBIO DIAGNOSTICS INC (CEMI) Latest news and press-releases to stay up to date.
Does CHEMBIO DIAGNOSTICS INC (CEMI) stock pay dividends?
CEMI does not pay a dividend.
When does CHEMBIO DIAGNOSTICS INC (CEMI) report earnings?
CHEMBIO DIAGNOSTICS INC (CEMI) will report earnings on 2023-05-09.
What is the Price/Earnings (PE) ratio of CHEMBIO DIAGNOSTICS INC (CEMI)?
CHEMBIO DIAGNOSTICS INC (CEMI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.75).
CEMI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CEMI. When comparing the yearly performance of all stocks, CEMI is one of the better performing stocks in the market, outperforming 82.43% of all stocks.
CEMI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CEMI. Both the profitability and financial health of CEMI have multiple concerns.
CEMI Financial Highlights
Over the last trailing twelve months CEMI reported a non-GAAP Earnings per Share(EPS) of -0.75. The EPS increased by 45.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
CEMI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to CEMI. The Buy consensus is the average rating of analysts ratings from 6 analysts.